This company listing is no longer active
Emplicure Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Emplicure's earnings have been declining at an average annual rate of -36.9%, while the Pharmaceuticals industry saw earnings growing at 12.9% annually. Revenues have been growing at an average rate of 48.3% per year.
Belangrijke informatie
-36.9%
Groei van de winst
-7.1%
Groei van de winst per aandeel
| Pharmaceuticals Groei van de industrie | 30.5% |
| Inkomstengroei | 48.3% |
| Rendement op eigen vermogen | -129.7% |
| Nettomarge | 19,935.0% |
| Laatste winstupdate | 30 Sep 2023 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe Emplicure geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Sep 23 | 0 | -27 | 26 | 0 |
| 30 Jun 23 | 1 | -26 | 25 | 0 |
| 31 Mar 23 | 1 | -29 | 25 | 0 |
| 31 Dec 22 | 1 | -30 | 24 | 0 |
| 30 Sep 22 | 1 | -26 | 8 | 0 |
| 31 Mar 22 | 0 | -24 | 10 | 0 |
| 31 Dec 21 | 0 | -18 | 6 | 0 |
| 30 Sep 21 | 0 | -15 | 11 | 0 |
| 31 Dec 20 | 0 | -5 | 2 | 0 |
Kwaliteitswinsten: EMPLI is currently unprofitable.
Groeiende winstmarge: EMPLI is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: Insufficient data to determine if EMPLI's year-on-year earnings growth rate was positive over the past 5 years.
Versnelling van de groei: Unable to compare EMPLI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: EMPLI is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (2.8%).
Rendement op eigen vermogen
Hoge ROE: EMPLI has a negative Return on Equity (-129.73%), as it is currently unprofitable.